by EmpathiCSubstanceS | Apr 25, 2021 | Psychedelic Medicine
Surfing the wave of novel research into medical uses for psychedelic compounds, the Icahn School of Medicine at Mount Sinai has launched a dedicated psychedelic center focusing initially on the study of MDMA and psilocybin for PTSD and other stress-related conditions...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, MDMA Sassafras Molly
A team of Australian scientists has demonstrated a novel microencapsulation method designed to improve the absorption and bioavailability of cannabidiol (CBD). Animal tests suggest the new method increases peak concentrations of CBD in the brain by 300 percent...
by EmpathiCSubstanceS | Apr 25, 2021 | Microdosing
A novel Australian trial is set to investigate the popular yet still deeply unproven practice of microdosing psychedelics. The research promises to be the first exploration of naturalistic psilocybin microdosing in a lab-setting using a cutting-edge neuroimaging...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
New research from scientists at Stanford University School of Medicine suggests cannabis use can be linked to higher rates of “rebound headaches” in migraine sufferers. The research is observational and retrospective, but it is yet another...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Cannabidiol, better known as CBD, is rapidly gaining popularity as a potion to treat almost every kind of medical concern you can think of, but scientific evidence is scant outside of a few clinically proven indications. A new study from a team of Canadian researchers...
